Thrombospondin 2 Promotes IL-6 Production in Osteoarthritis Synovial Fibroblasts via the PI3K/AKT/NF-κB Pathway

被引:14
|
作者
Hou, Chun-Han [1 ]
Tang, Chih-Hsin [2 ,3 ,4 ,5 ]
Chen, Po-Chun [5 ,6 ,7 ]
Liu, Ju-Fang [7 ,8 ]
机构
[1] Natl Taiwan Univ Hosp, Dept Orthoped Surg, Taipei, Taiwan
[2] China Med Univ, Sch Med, Taichung, Taiwan
[3] China Med Univ, Grad Inst Biomed Sci, Taichung, Taiwan
[4] China Med Univ, Chinese Med Res Ctr, Taichung, Taiwan
[5] Asia Univ, Coll Hlth Sci, Dept Biotechnol, Taichung, Taiwan
[6] Shin Kong Wu Ho Su Mem Hosp, Translat Med Ctr, Taipei, Taiwan
[7] China Med Univ, China Med Univ Hosp, Dept Med Res, Taichung, Taiwan
[8] Taipei Med Univ, Coll Oral Med, Sch Oral Hyg, 250 Wu Hsing St, Taipei 11031, Taiwan
关键词
TSP2; osteoarthritis; integrin alpha(v)beta(3); IL-6; OLIGOMERIC MATRIX PROTEIN; ARTICULAR-CARTILAGE; SIGNALING PATHWAY; BONE-FORMATION; UP-REGULATION; CELL; EXPRESSION; RECEPTOR; MICE; INFLAMMATION;
D O I
10.2147/JIR.S314747
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Background: It is known that osteoarthritis (OA) pathogenesis involves inflammation that drives pathologic changes and that the matricellular protein, thrombospondin-2 (TSP2), is involved in angiogenesis, carcinogenesis, and inflammation. However, how TSP2 contributes to OA inflammatory processes is unclear. Objective: The aim of current study was to elucidate whether TSP2 could promote interleukin6 (IL-6), a pro-inflammatory cytokine, expression in osteoarthritis synovial fibroblasts (OASFs). Methods: The synovial fibroblasts isolated from osteoarthritis and healthy donors were incubated with recombinant TSP2 to evaluate its effect in OA pathogenesis. The SFs were incubated with recombinant TSP2, followed by determining the IL-6 expression by qPCR and Western blot. After SFs were incubated with TSP2 for different time interval, the Western blot was performed to investigate the activation of signal pathway. The different strategies including neutralizing antibodies, siRNAs, and chemical inhibitors were used to discover the signal transduction in response to TSP2 incubation in OASFs. To evaluate the therapeutic potential of TSP2 in osteoarthritis, the anterior cruciate ligament transection (ACLT) in SD rats was performed in the presence or absence of TSP neutralizing antibody treatment. Results: Our investigations have revealed that TSP2 promoted IL-6 expression in OASFs in a dose-dependent manner, especially in 30 and 100 ng/mL concentration (p < 0.05). Using different strategies including neutralizing antibodies, siRNAs, and chemical inhibitors, all of which attenuated signal pathway components in OASFs, we found evidence for the involvement of integrin alpha(v)beta(3), PI3K, Akt, and NF-kappa B in TSP2-mediated upregulation of IL-6 (p < 0.05). Finally, in the result of rat ACLT surgical model, we found that TSP2 neutralizing antibody had protective effects in cartilage destruction during OA progression. Conclusion: Thrombospondin-2 palys an important role in osteoarthritis pathogenesis and provides an opportunity to deal with osteoarthritis.
引用
收藏
页码:5955 / 5967
页数:13
相关论文
共 50 条
  • [41] AKR1B10 promotes breast cancer cell proliferation and migration via the PI3K/AKT/NF-κB signaling pathway
    Qu, Jiayao
    Li, Jia
    Zhang, Yaming
    He, Rongzhang
    Liu, Xiangting
    Gong, Ke
    Duan, Lili
    Luo, Weihao
    Hu, Zheng
    Wang, Gengsheng
    Xia, Chenglai
    Luo, Dixian
    CELL AND BIOSCIENCE, 2021, 11 (01)
  • [42] Arctigenin prevents the progression of osteoarthritis by targeting PI3K/Akt/NF-κB axis: In vitro and in vivo studies
    Tang, Shangkun
    Zhou, Weijun
    Zhong, Xinyang
    Xu, Jianchen
    Huang, Huasong
    Zheng, Xinnan
    Zhang, Jingkang
    Yang, Shuyue
    Shang, Ping
    Tang, Qian
    Liu, Haixiao
    JOURNAL OF CELLULAR AND MOLECULAR MEDICINE, 2020, 24 (07) : 4183 - 4193
  • [43] HMGB-1 Induces IL-6 Production in Human Synovial Fibroblasts Through c-Src, Akt and NF-κB Pathways
    Hou, Chun-Han
    Fong, Yi-Chin
    Tang, Chih-Hsin
    JOURNAL OF CELLULAR PHYSIOLOGY, 2011, 226 (08) : 2006 - 2015
  • [44] Perfluorooctane sulfonate mediates secretion of IL-1β through PI3K/AKT NF-κB pathway in astrocytes
    Chen, Xiaoxu
    Nie, Xiaoke
    Mao, Jiamin
    Zhang, Yan
    Yin, Kaizhi
    Sun, Pingping
    Luo, Jiashan
    Liu, Yiming
    Jiang, Shengyang
    Sun, Lingli
    NEUROTOXICOLOGY AND TERATOLOGY, 2018, 67 : 65 - 75
  • [45] TRAF5 promotes the occurrence and development of colon cancer via the activation of PI3K/AKT/NF-κB signaling pathways
    Sun, G.
    Zheng, C.
    Deng, Z.
    Huang, C.
    Huang, J.
    JOURNAL OF BIOLOGICAL REGULATORS AND HOMEOSTATIC AGENTS, 2020, 34 (04) : 1257 - 1268
  • [46] Flotillin-2 promotes metastasis of nasopharyngeal carcinoma by activating NF-κB and PI3K/Akt3 signaling pathways
    Liu, Jie
    Huang, Wei
    Ren, Caiping
    Wen, Qiuyuan
    Liu, Weidong
    Yang, Xuyu
    Wang, Lei
    Zhu, Bin
    Zeng, Liang
    Feng, Xiangling
    Zhang, Chang
    Chen, Huan
    Jia, Wei
    Zhang, Lihua
    Xia, Xiaomeng
    Chen, Yuxiang
    SCIENTIFIC REPORTS, 2015, 5
  • [47] The gene RAD51AP1 promotes the progression of pancreatic cancer via the PI3K/Akt/NF-κB signaling pathway
    Wang, Yongkun
    Li, Yingchun
    Ran, Cui
    Le, Wenjun
    Dong, Jiaxing
    Wang, Xujing
    Chen, Bo
    Jiang, Xiaohua
    NEOPLASMA, 2023, 70 (06) : 722 - +
  • [48] Toll-like receptor 2 stimulation promotes colorectal cancer cell growth via PI3K/Akt and NF-κB signaling pathways
    Liu, You Dong
    Ji, Cheng Bo
    Li, Shan Bao
    Yan, Feng
    Gu, Qi Sheng
    Balic, Jesse J.
    Yu, Liang
    Li, Ji Kun
    INTERNATIONAL IMMUNOPHARMACOLOGY, 2018, 59 : 375 - 383
  • [49] Paeonol Inhibits IL-1β-Induced Inflammation via PI3K/Akt/NF-κB Pathways: In Vivo and Vitro Studies
    Lou, Yiting
    Wang, Chenggui
    Tang, Qian
    Zheng, Wenhao
    Feng, Zhenhua
    Yu, Xingfang
    Guo, Xiaoshan
    Wang, Jianshun
    INFLAMMATION, 2017, 40 (05) : 1698 - 1706
  • [50] Asperulosidic acid inhibits the PI3K/Akt/NF-κB pathway to suppress endotoxin-induced uveitis
    Du, Yong
    Lu, Jing
    Feng, Lujia
    Zhao, Long
    Wu, Ping
    He, Yuxia
    Zhou, Linbin
    Wang, Xing
    Peng, Hui
    FRONTIERS IN MEDICINE, 2025, 11